Roth Capital raised the firm’s price target on Gentherm (THRM) to $44 from $42 and keeps a Buy rating on the shares. The company’s Q3 execution was good, with Gentherm turning in modest outperformance of industry production in core climate/comfort products while absorbing higher material and footprint realignment costs, resulting in an adjusted EBITDA beat, the analyst tells investors in a research note. Awards for Gentherm also remain strong, with conquest lumbar/massage wins driving good new program bookings, Roth added.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THRM: